Related Experiment Videos
Screening for lung cancer: New horizons?
Antonio Rossi1, Paolo Maione, Giuseppe Colantuoni
1Unità Operativa di Oncologia Medica, Azienda Ospedaliera "S.G. Moscati", Contrada Amoretta, Città Ospedaliera, 83100 Avellino, Italy. arossi_it@yahoo.it
Critical Reviews in Oncology/Hematology
|June 28, 2005
Summary
Lung cancer screening aims to detect the disease early for better cure rates. Low-dose computed tomography (CT) shows promise, but further trials are needed to confirm its effectiveness in mass screening programs.
Area of Science:
- Oncology
- Pulmonology
- Radiology
Background:
- Lung cancer is the leading cause of cancer mortality globally.
- Surgical resection offers the highest cure rates but is only effective at early disease stages.
- Early detection through screening is crucial for reducing lung cancer mortality.
Purpose of the Study:
- To review current lung cancer screening methods.
- To evaluate the utility of low-dose computed tomography (CT) for lung cancer screening.
- To discuss future screening approaches.
Main Methods:
- Review of existing clinical trials on chest X-ray, sputum cytology, and low-dose CT.
- Discussion of the advantages of CT over chest X-ray.
- Exploration of emerging screening technologies.
Main Results:
- Low-dose CT offers potential advantages for lung cancer screening compared to chest X-ray.
- Further controlled trials are required to establish the definitive role of CT in mass screening.
- Positron emission tomography (PET), autofluorescence bronchoscopy, and biomarkers show future promise.
Conclusions:
- Early detection of lung cancer through effective screening strategies is essential.
- Low-dose CT screening requires further validation through rigorous trials.
- Novel screening modalities hold significant potential for improving lung cancer outcomes.